Invasive monitoring

Published on 07/02/2015 by admin

Filed under Anesthesiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 1.5 (2 votes)

This article have been viewed 10213 times

Invasive monitoring

Invasive arterial pressure monitoring

Invasive arterial pressure monitoring provides beat-to-beat real-time information with sustained accuracy.

Components

1. An indwelling Teflon arterial cannula (20 or 22 G) is used (Fig. 11.1). The cannula has parallel walls to minimize the effect on blood flow to the distal parts of the limb. Cannulation can be achieved by directly threading the cannula (either by direct insertion method or a transfixation technique) or by using a modified Seldinger technique with a guidewire to assist in the insertion as in some designs (Fig. 11.2).

2. A column of bubble-free heparinized or plain 0.9% normal saline at a pressure of 300 mmHg, incorporating a flushing device.

3. Via the fluid column, the cannula is connected to a transducer (Figs 11.311.5). This in turn is connected to an amplifier and oscilloscope. A strain gauge variable resistor transducer is used.

4. The diaphragm (a very thin membrane) acts as an interface between the transducer and the fluid column.

5. The pressure transducer is a device that changes either electrical resistance or capacitance in response to changes in pressure on a solid-state device. The moving part of the transducer is very small and has little mass.

Mechanism of action

1. The saline column moves back and forth with the arterial pulsation causing the diaphragm to move. This causes changes in the resistance and current flow through the wires of the transducer.

2. The transducer is connected to a Wheatstone bridge circuit (Fig. 11.6). This is an electrical circuit for the precise comparison of resistors. It uses a null-deflection system consisting of a very sensitive galvanometer and four resistors in two parallel branches: two constant resistors, a variable resistor and the unknown resistor. Changes in resistance and current are measured, electronically converted and displayed as systolic, diastolic and mean arterial pressures. The Wheatstone bridge circuit is ideal for measuring the small changes in resistance found in strain gauges. Most pressure transducers contain four strain gauges that form the four resistors of the Wheatstone bridge.

3. The flushing device allows 3–4 mL per hour of saline (or heparinized saline) to flush the cannula. This is to prevent clotting and backflow through the catheter. Manual flushing of the system is also possible when indicated.

4. The radial artery is the most commonly used artery because the ulnar artery is the dominant artery in the hand. The ulnar artery is connected to the radial artery through the palmar arch in 95% of patients. The brachial, femoral, ulnar or dorsalis pedis arteries are used occasionally.

5. The information gained from invasive arterial pressure monitoring includes heart rate, pulse pressure, the presence of a respiratory swing, left ventricular contractility, vascular tone (SVR) and stroke volume.

The arterial pressure waveform

1. This can be characterized as a complex sine wave that is the summation of a series of simple sine waves of different amplitudes and frequencies.

2. The fundamental frequency (or first harmonic) is equal to the heart rate, so a heart rate of 60 beats per min = 1 beat/s or 1 cycle/s or 1 Hz. The first 10 harmonics of the fundamental frequency contribute to the waveform.

3. The system used to measure arterial blood pressure should be capable of responding to a frequency range of 0.5–40 Hz in order to display the arterial waveform correctly.

4. The dicrotic notch in the arterial pressure waveform represents changes in pressure because of vibrations caused by the closure of the aortic valve.

5. The rate of rise of the upstroke part of the wave (dP/dt) reflects the myocardial contractility. A slow rise upstroke might indicate a need for inotropic support. A positive response to the inotropic support will show a steeper upstroke. The maximum upward slope of the arterial waveform during systole is related to the speed of ventricular ejection.

6. The position of the dicrotic notch on the downstroke of the wave reflects the peripheral vascular resistance. In vasodilated patients, e.g. following an epidural block or in septic patients, the dicrotic notch is positioned lower on the curve. The notch is higher in vasoconstricted patients.

7. The downstroke slope indicates resistance to outflow. A slow fall is seen in vasoconstriction.

8. The stroke volume can be estimated by measuring the area from the beginning of the upstroke to the dicrotic notch. Multiply that by the heart rate and the cardiac output can be estimated.

9. Systolic time indicates the myocardial oxygen demand. Diastolic time indicates myocardial oxygen supply.

10. Mean blood pressure is the average pressure throughout the cardiac cycle. As systole is shorter than diastole, the mean arterial pressure (MAP) is slightly less than the value half way between systolic and diastolic pressures. An estimate of MAP can be obtained by adding a third of the pulse pressure (systolic − diastolic pressure) to the diastolic pressure. MAP can also be determined by integrating a pressure signal over the duration of one cycle, divided by time.

The natural frequency

This is the frequency at which the monitoring system itself resonates and amplifies the signal by up to 20–40%. This determines the frequency response of the monitoring system. The natural frequency should be at least 10 times the fundamental frequency. The natural frequency of the measuring system is much higher than the primary frequency of the arterial waveform which is 1–2 Hz, corresponding to a heart rate of 60–120 beats/min. Stiffer (low compliance) tubing or a shorter length of tubing (less mass) produce higher natural frequencies. This results in the system requiring a much higher pulse rate before amplification.

The natural frequency of the monitoring system is:

Problems in practice and safety features

1. The arterial pressure waveform should be displayed (Fig. 11.7) in order to detect damping or resonance. The monitoring system should be able to apply an optimal damping value of 0.64.

a) Damping is caused by dissipation of stored energy. Anything that takes energy out of the system results in a progressive diminution of amplitude of oscillations. Increased damping lowers the systolic and elevates the diastolic pressures with loss of detail in the waveform. Damping can be caused by an air bubble (air is more compressible in comparison to the saline column), clot or a highly compliant, soft transducer diaphragm and tube.

b) Resonance occurs when the frequency of the driving force coincides with the resonant frequency of the system. If the natural frequency is less than 40 Hz, it falls within the range of the blood pressure and a sine wave will be superimposed on the blood pressure wave. Increased resonance elevates the systolic and lowers the diastolic pressures. The mean pressure should stay unchanged. Resonance can be due to a stiff, non-compliant diaphragm and tube. It is worse with tachycardia.

2. To determine the optimum damping of the system, a square wave test (fast flush test) is used (Fig. 11.8). The system is flushed by applying a pressure of 300 mmHg (compress and release the flush button or pull the lever located near the transducer). This results in a square waveform, followed by oscillations:

3. The transducer should be positioned at the level of the right atrium as a reference point that is at the level of the midaxillary line. Raising or lowering the transducer above or below the level of the right atrium gives error readings equivalent to 7.5 mmHg for each 10 cm.

4. Ischaemia distal to the cannula is rare but should be monitored for. Multiple attempts at insertion and haematoma formation increase the risk of ischaemia.

5. Arterial thrombosis occurs in 20–25% of cases with very rare adverse effects such as ischaemia or necrosis of the hand. Cannulae in place for less than 24 h very rarely cause thrombosis.

6. The arterial pressure wave narrows and increases in amplitude in peripheral vessels. This makes the systolic pressure higher in the dorsalis pedis than in the radial artery. When compared to the aorta, peripheral arteries contain less elastic fibres so they are stiffer and less compliant. The arterial distensibility determines the amplitude and contour of the pressure waveform. In addition, the narrowing and bifurcation of arteries leads to impedance of forward blood flow, which results in backward reflection of the pressure wave.

7. There is risk of bleeding due to disconnection.

8. Inadvertent drug injection causes distal vascular occlusion and gangrene. An arterial cannula should be clearly labelled.

9. Local infection is thought to be less than 20%. Systemic infection is thought to be less than 5%. This is more common in patients with an arterial cannula for more than 4 days with a traumatic insertion.

10. Arterial cannulae should not be inserted in sites with evidence of infection and trauma or through a vascular prosthesis.

11. Periodic checks, calibrations and re-zeroing are carried out to prevent baseline drift of the transducer electrical circuits. Zero calibration eliminates the effect of atmospheric pressure on the measured pressure. This ensures that the monitor indicates zero pressure in the absence of applied pressure, so eliminating the offset drift (zero drift). To eliminate the gradient drift, calibration at a higher pressure is necessary. The transducer is connected to an aneroid manometer using a sterile tubing, through a three-way stopcock and the manometer pressure is raised to 100 and 200 mmHg. The monitor display should read the same pressure as is applied to the transducer (Fig. 11.9).

Central venous catheterization and pressure (CVP)

The CVP is the filling pressure of the right atrium. It can be measured directly using a central venous catheter. The catheter can also be used to administer fluids, blood, drugs, parenteral nutrition and sample blood. Specialized catheters can be used for haemofiltration, haemodialysis (see Chapter 13, Haemofiltration) and transvenous pacemaker placement.

The tip of the catheter is usually positioned in the superior vena cava at the entrance to the right atrium. The internal jugular, subclavian and basilic veins are possible routes for central venous catheterization. The subclavian route is associated with the highest rate of complications but is convenient for the patient and for the nursing care.

The Seldinger technique is the common and standard method used for central venous catheterization (Fig. 11.10) regardless of catheter type. The procedure should be done under sterile conditions:

1. Introduce the needle into the vein using the appropriate landmarks or an ultrasound-locating device.

2. A J-shaped soft tip guidewire is introduced through the needle (and syringe in some designs) into the vein. The needle can then be removed. The J-shaped tip is designed to minimize trauma to the vessels’ endothelium.

3. After a small incision in the skin has been made, a dilator is introduced over the guidewire to make a track through the skin and subcutaneous tissues and is then withdrawn.

4. The catheter is then railroaded over the guidewire into its final position before the guidewire is withdrawn.

5. Blood should be aspirated easily from all ports which should then be flushed with saline or heparin solution. All the port sites that are not intended for immediate use are sealed. A port should never be left open to air during insertion because of the risk of air embolism.

6. The catheter is secured onto the skin and covered with a sterile dressing.

7. A chest X-ray is performed to ensure correct positioning of the catheter and to detect pneumo-and/or haemothorax.

8. The use of ultrasound guidance should be routinely considered for the insertion of central venous catheters (Fig. 11.11). There is evidence to show that its use during internal jugular venous catheterization reduces the number of mechanical complications, the number of catheter-placement failures and the time required for insertion.

The CVP is read using either a pressure transducer or a water manometer.

Fluid manometer (Fig. 11.12)

1. A giving set with either normal saline or 5% dextrose is connected to the vertical manometer via a three-way tap. The latter is also connected to the central venous catheter.

2. The manometer has a spirit level side arm positioned at the level of the right atrium (zero reference point). The upper end of the column is open to air via a filter. This filter must stay dry to maintain direct connection with the atmosphere.

3. The vertical manometer is filled to about the 20-cm mark. By opening the three-way tap to the patient, a swing of the column should be seen with respiration. The CVP is read in cm H2O when the fluid level stabilizes.

4. The manometer uses a balance of forces: downward pressure of the fluid (determined by density and height) against pressure of the central venous system (caused by hydrostatic and recoil forces).

In both techniques, the monitoring system has to be zeroed at the level of the right atrium (usually at the midaxillary line). This eliminates the effect of hydrostatic pressure on the CVP value.

Catheters

There are different types of catheters used for central venous cannulation and CVP measurement. They differ in their lumen size, length, number of lumens, the presence or absence of a subcutaneous cuff and the material they are made of. The vast majority of catheters are designed to be inserted using the Seldinger technique although some are designed as ‘long’ intravenous cannulae (cannula over a needle) (Fig. 11.13).

Antimicrobial-coated catheters have been designed to reduce the incidence of catheter-related bloodstream infection. These can be either antiseptic coated (e.g. chlorhexidine/silver sulfadiazine, benzalkonium chloride, platinum/silver) or antibiotic coated (e.g. minocycline/rifampin) on either the internal or external surface or both. The antibiotic-coated central lines are thought to be more effective in reducing the incidence of infection (Fig. 11.14).

Hickman catheters

1. These central catheters are made of polyurethane or silicone and are usually inserted into the subclavian vein. The catheter can have one, two or three lumens (Fig. 11.18).

2. The proximal end is tunnelled under the skin for a distance of about 10 cm.

3. A Dacron cuff is positioned 3–4 cm from the site of entry into the vein under the skin. It induces a fibroblastic reaction to anchor the catheter in place (Fig. 11.19). The cuff also reduces the risk of infection as it stops the spread of infection from the site of entry to the skin. Some catheters also have a silver impregnated cuff that acts as an anti-microbial barrier.

4. They are used for long-term chemotherapy, parenteral nutrition, blood sampling or as a readily available venous access especially in children requiring frequent anaesthetics during cancer treatment.

5. These lines are designed to remain in situ for several months unless they become infected but require some degree of daily maintenance.

Dialysis catheters

These are large-calibre catheters designed to allow high flow rates of at least 300 mL/min. They are made of silicone or polyurethane. Most of them are dual lumen with staggered end and side holes to prevent admixture of blood at the inflow and outflow portions reducing recirculation.

Problems in practice and safety features

1. Inaccurate readings can be due to catheter blockage, catheter inserted too far or using the wrong zero level.

2. Pneumohaemothorax (with an incidence of 2–10% with subclavian vein catheterization and 1–2% with internal jugular catheterization), trauma to the arteries (carotid, subclavian and brachial), air embolism, haematoma and tracheal puncture are complications of insertion.

3. Sepsis and infection are common complications with an incidence of 2.8–20%. Staphylococcus aureus and Enterococcus are the most common organisms.

Guidelines for reduction in sepsis and infection rates with the use of central venous catheters

• Education and training of staff who insert and maintain the catheters.

• Use the maximum sterile barrier precautions during central venous catheter insertion.

• Use of >0.5% chlorhexidine preparation with alcohol preparations for skin antisepsis. If there is a contraindication to chlorhexidine, tincture of iodine, an iodophor or 70% alcohol can be used as alternative. Antiseptics should be allowed to dry according to the manufacturer’s recommendation prior to placing the catheter.

• Use a subclavian site, rather than a jugular or a femoral site, in adult patients to minimize infection risk for non-tunneled CVC placement.

• Use ultrasound guidance to place central venous catheters (if this technology is available) to reduce the number of cannulation attempts and mechanical complications. Ultrasound guidance should only be used by those fully trained in its technique.

• Use a CVC with the minimum number of ports or lumens essential for the management of the patient.

• Promptly remove any intravascular catheter that is no longer essential.

• When adherence to aseptic technique cannot be ensured (i.e. catheters inserted during a medical emergency), replace the catheter as soon as possible, i.e. within 48 h.

• Use either sterile gauze or sterile, transparent, semipermeable dressing to cover the catheter site.

• Use a chlorhexidine/silver sulfadiazine or minocycline/rifampin-impregnated CVC in patients whose catheter is expected to remain in place >5 days.

(Centers for Disease Control. 2011. Guidelines for the prevention of intravascular catheter-related infections)

4. A false passage may be created if the guidewire or dilator are advanced against resistance. The insertion should be smooth.

5. There may be cardiace complications such as self-limiting arrhythmias due to the irritation caused by the guidewire or catheter. Gradual withdrawal of the device is usually adequate to restore normal rhythm. More serious but unusual complication such as venous or cardiac perforation can be lethal.

6. Catheter-related venous thrombosis is thought to be up to 40% depending on the site, the duration of placement, the technique and the condition of the patient.

7. Microshock. A central venous catheter presents a direct pathway to the heart muscle. Faulty electrical equipment can produce minute electrical currents (less than 1 ampere) which can travel via this route to the myocardium. This can produce ventricular fibrillation (VF) if the tip of the catheter is in direct contact with the myocardium (see Chapter 14). This very small current does not cause any adverse effects if applied to the body surface, but if passed directly to the heart, the current density will be high enough to cause VF, hence the name microshock.

Invasive electrocardiogram (ECG)

In addition to using skin electrodes to record ECG, other more invasive methods can be used (Fig. 11.20). The following methods can be used:

1. Oesophageal ECG can be recorded by using oesophageal electrodes that are incorporated into an oesophageal stethoscope and temperature probe. It has been found to be useful in detecting atrial arrhythmias. As it is positioned near the posterior aspect of the left ventricle, it can be helpful in detecting posterior wall ischaemia.

2. Intracardiac ECG with electrodes inserted using a multipurpose pulmonary artery flotation catheter. There are three atrial and two ventricular electrodes. In addition to ECG recording, these electrodes can be used in atrial or AV pacing. Such ECG recording has great diagnostic capabilities and can be part of an implantable defibrillator. It is used for loci that cannot be assessed by body surface electrodes, such as the bundle of His or ventricular septal activity,

3. Tracheal ECG using two electrodes embedded into a tracheal tube. It is useful in diagnosing atrial arrhythmias especially in children

Cardiac output

Cardiac output monitoring (the measurement of flow, rather than pressure) has been the subject of a lot of technical development over the last decade. It is helpful to consider the history of this development briefly.

The pulmonary artery (PA) catheter was developed in the 1970s and was the only bed-side piece of equipment available to measure cardiac output. It gained widespread acceptance in the intensive care and anaesthetic community. However, it lost favour due to its technically demanding insertion. Also some papers appeared in journals during the late 1980s and mid 1990s associating its use with an increased mortality in patients. This has now been now refuted, however it remains challenging to insert in some circumstances.

As a result, there was a strong move to adopt less invasive technologies and develop them to replace the PA catheter.

The following techniques exist to provide measurement of cardiac output. Some use a combination of these, for example LiDCO, which uses lithium indicator dilution to calibrate its arterial waveform analysis software. Detailed discussion of each is beyond the scope of this book and the reader is referred to the further reading section.

1. Arterial waveform analysis either via direct arterial cannulation or ‘simulated’ via a plethysmographic trace (such as that obtained with the pulse oximeter):

2. Aortic velocimetry using:

3. Formal echocardiography:

4. Transthoracic impedence.

5. Pulmonary gas clearance.

6. Indicator dilution:

7. Electrical velocimetry (EV) is the technique which non-invasively measures rate-of-change of electrical conductivity of blood in the aorta using four standard ECG surface electrodes.

Balloon-tipped flow-guided pulmonary artery catheter

Pulmonary artery (PA) catheters are usually inserted via the internal jugular or subclavian veins via an introducer. They are floated through the right atrium and ventricle into the pulmonary artery.

Components

PA catheters are available in sizes 5–8 G and are usually 110 cm in length (Fig. 11.21). They have up to five lumens and are marked at 10-cm intervals:

1. The distal lumen ends in the pulmonary artery. It is used to measure PA and pulmonary capillary wedge (PCW) pressures and to sample mixed venous blood.

2. The proximal lumen should ideally open in the right atrium, being positioned about 30 cm from the tip of the catheter. It can be used to continuously monitor the CVP, to administer the injectate to measure the cardiac output (by thermodilution) or to infuse fluids. Depending on the design, a second proximal lumen may be present which is usually dedicated to infusions of drugs.

3. Another lumen contains two insulated wires leading to a thermistor that is about 3.7 cm from the catheter tip. Proximally it is connected to a cardiac output computer.

4. The balloon inflation lumen is used to inflate the balloon which is situated at the catheter tip.

Up to 1.5 mL of air is needed. When the balloon is inflated, the catheter floats with the blood flow into a pulmonary artery branch (Fig. 11.22).

Mechanism of action

1. Before insertion, flush all the lines and test the balloon with 1–1.5 mL of air.

2. The distal lumen of the catheter is connected to a transducer pressure measuring system for continuous monitoring as the catheter is advanced. As the catheter passes via the superior vena cava to the right atrium, low pressure waves (mean of 3–8 mmHg normally) are displayed (Fig. 11.23). The distance from the internal jugular or the subclavian vein to the right atrium is about 15–20 cm.

3. The balloon is partly inflated, enabling the blood flow to carry the catheter tip through the tricuspid valve into the right ventricle. Tall pressure waves (15–25 mmHg systolic and 0–10 mmHg diastolic) are displayed.

4. As the balloon tip floats through the pulmonary valve into the PA, the pressure waveform changes with higher diastolic pressure (10–20 mmHg), but similar systolic pressures. The dicrotic notch, caused by the closure of the pulmonary valve, can be noted. The distance from the right ventricle to the pulmonary artery should be less than 10 cm, unless there is cardiomegaly.

5. The balloon is fully inflated enabling the blood flow to carry the tip of the catheter into a pulmonary artery branch, where it wedges. This is shown as a damped pressure waveform (pulmonary capillary wedge pressure (PCWP), mean pressure of 4–12 mmHg). This reflects the left atrial filling pressure. The balloon should then be deflated so the catheter floats back into the PA. The balloon should be kept deflated until another PCWP reading is required.

6. The cardiac output can be measured using thermodilution. Ten mL of cold injectate is administered upstream via the proximal lumen. The thermistor (in the pulmonary artery) measures the change in temperature of the blood downstream. A temperature–time curve is displayed from which the computer can calculate the cardiac output (Fig. 11.24). The volume of injectate should be known accurately and the whole volume injected quickly. Usually the mean of three readings is taken. Because of the relatively high incidence of complications, less invasive techniques are being developed to measure the cardiac output. Thermodilution remains the standard method for measuring the cardiac output.

7. Some designs have the facility to continuously monitor the mixed venous oxygen saturation using fibreoptic technology (Figs 11.25 and 11.26). Cardiac pacing capability is present in some designs.

Problems in practice and safety features

The overall morbidity of such catheters is 0.4%.

1. Complications due to central venous cannulation (as above).

2. Complications due to catheter passage and advancement. These include arrhythmias (ventricular ectopics, ventricular tachycardia and others), heart block, knotting/kinking (common in low-flow states and patients with large hearts; a ‘rule of thumb’ is that the catheter should not be advanced more than 10–15 cm without a change in the pressure waveform), valvular damage and perforation of PA vessel.

3. Complications due to the presence in the PA. These include thrombosis (can be reduced by the use of heparin-bonded catheters), PA rupture (more common in the elderly, may present as haemoptysis and is often fatal), infection, balloon rupture, pulmonary infarction, valve damage and arrhythmias.

4. In certain conditions, the PCWP does not accurately reflect left ventricular filling pressure. Such conditions include mitral stenosis and regurgitation, left atrial myxoma, ball valve thrombus, pulmonary veno-occlusive disease, total anomalous pulmonary venous drainage, cardiac tamponade and acute right ventricular dilatation resulting from right ventricular infarction, massive pulmonary embolism and acute severe tricuspid regurgitation.

5. Catheter whip can occur because of the coursing of the pulmonary catheter through the right heart. Cardiac contractions can produce ‘shock transients’ or ‘whip’ artifacts. Negative deflections due to a whip artifact may lead to an underestimation of pulmonary artery pressures.

Oesophageal Doppler haemodynamic measurement

An estimate of cardiac output can be quickly obtained using the minimally invasive oesophageal Doppler. Patient response to therapeutic manoeuvres (e.g. fluid challenge) can also be rapidly assessed. The technique has the advantage of the smooth muscle tone of the oesophagus acting as a natural means of maintaining the probe in position for repeated measurements. In addition, the oesophagus is in close anatomical proximity to the aorta so that signal interference from bone, soft tissue and lung is minimized. Over the past three decades, the oesophageal Doppler has evolved from an experimental technique to a relatively simple bed-side procedure with the latest models incorporating both Doppler and echo-ultrasound in a single probe.

The measurement of cardiac output using the oesophageal Doppler method correlates well with that obtained from a pulmonary artery catheter. Oesophageal Doppler ultrasonography has been used for intravascular volume optimization in both the perioperative period and in the critical care setting. Its use in cardiac, general and orthopaedic surgery has been associated with a reduction in morbidity and hospital stay. Because of the mild discomfort associated with placing the probe and maintaining it in a fixed position, patients require adequate sedation.

Mechanism of action

1. The device relies on the Doppler principle. There is an increase in observed frequency of a signal when the signal source approaches the observer and a decrease when the source moves away.

2. The changes in the frequency of the transmitted ultrasound result from the encounter of the wavefront with moving red blood cells. If the transmitted sound waves encounter a group of red cells moving towards the source, they are reflected back at a frequency higher than that at which they were sent, producing a positive Doppler shift. The opposite effect occurs when a given frequency sent into tissues encounters red cells moving away. The result is the return of a frequency lower than that transmitted, resulting in a negative Doppler shift. Analysis of the reflected frequencies allows determination of velocity of flow.

3. The lubricated probe is inserted via the mouth with the bevel of the tip facing up at the back of the patient’s throat into the distal oesophagus to a depth of about 35–40 cm from the teeth.

4. The probe is rotated and slowly pulled back while listening to the audible signal. The ideal probe tip location is at the level between the fifth and sixth thoracic vertebrae because, at that level, the descending aorta is adjacent and parallel to the distal oesophagus. This location is achieved by superficially landmarking the distance to the third sternocostal junction anteriorly. A correctly positioned probe can measure the blood flow in this major vessel using a high ultrasound frequency of 4 MHz.

5. The Doppler signal waveform is analysed and the stroke volume and total cardiac output are computed using the Doppler equation and a normogram which corrects for variations found with differing patient age, sex and body surface area.

6. The parameters obtained from analysis of the Doppler signal waveform allow the operator to gain an assessment of cardiac output, stroke volume, volaemic status, systemic vascular resistance and myocardial function (Fig. 11.28).

Problems in practice and safety features

LiDCOrapid

This is a cardiac output monitor that uses arterial pressure waveform analysis software to generate a ‘nominal’ cardiac output value. Because it does not require calibration, it can be quickly set up and the effects of fluids or inotropes assessed (Fig. 11.29).

Temperature probes

Monitoring a patient’s temperature during surgery is a common and routine procedure. Different types of thermometers are available.

Thermistor

Mechanism of action

Infrared tympanic thermometer

Thermocouples

These are devices that make use of the principle that two different metals in contact generate a voltage, which is temperature dependent (Fig. 11.30).

image

Fig. 11.30 Thermocouple.

Mechanism of action

1. One junction is used as the measuring junction whereas the other one is the reference. The latter is kept at a constant temperature.

2. The metals expand and contract to different degrees with change in temperature producing an electrical potential that is compared to a reference junction. The current produced is directly proportional to the temperature difference between the two junctions, i.e. there is a linear relationship between voltage and temperature.

3. The voltage produced is called the Seebeck effect or thermoelectric effect.

4. The measuring junction produces a potential of 40 µV per °C. This potential is measured by an amplifier.

5. They are stable and accurate to 0.1°C.

6. If multiple thermocouples are linked in series, they constitute a thermopile. This is done to improve their sensitivity

Body core temperature can be measured using different sites:

1. Rectal temperature does not accurately reflect the core temperature in anaesthetized patients. During an operation, changes in temperature are relatively rapid and the rectal temperature lags behind.

2. Oesophageal temperature accurately reflects the core temperature with the probe positioned in the lower oesophagus (at the level of the left atrium). Here the probe is not affected by the cooler tracheal temperature (Fig. 11.31).

3. Tympanic membrane temperature is closely associated with brain temperature. It accurately reflects core temperature, compared with lower oesophageal temperature. Thermocouple and thermistor probes as well as the infrared probe can be used (Figs 11.32 and 11.33).

4. Bladder temperature correlates well with the core temperature when there is a normal urine output (Fig. 11.34).

5. Skin temperature, when measured with the core temperature, can be useful in determining the volaemic status of the patient (Fig. 11.35).

The axilla is the best location for monitoring muscle temperature, making it most suitable for detecting malignant hyperthermia.

MCQs

In the following lists, which of the statements (a) to (e) are true?

1. Thermometers:

2. Concerning direct arterial blood pressure measurement:

3. Balloon-tipped flow-guided pulmonary artery catheter:

4. If the mean arterial blood pressure is 100 mmHg, pulmonary capillary wedge pressure is 10 mmHg, mean pulmonary artery pressure is 15 mmHg, cardiac output is 5 L/min and CVP is 5 mmHg, which of the following statements are correct?

5. Concerning central venous pressure and cannulation:

6. In an invasive pressure measurement system, which of the following is/are correct:

7. Concerning the oesophageal Doppler:

Answers

1. Thermometers:

a) True. The response is non-linear but can be made linear electronically.

b) False. Thermistors are used in measuring the cardiac output by thermodilution. Thermocouples are not used in measuring the cardiac output by thermodilution.

c) True. The Seebeck effect is when the electrical potential produced at the junction of two dissimilar metals is dependent on the temperature of the junction. This is the principle used in thermocouples.

d) True. The gradient between the core and peripheral temperatures is useful in assessing the degree of skin perfusion and the circulatory volume. For example, hypovolaemia causes a decrease in skin perfusion which reduces the peripheral temperature and thus increases the gradient. The normal gradient is about 2–4°C.

e) True. The galvanometer is placed between the junctions of the thermocouple, the reference and the measuring junctions. This allows the current to be measured. Changes in current are calibrated to measure the temperature difference between the two junctions.

2. Concerning direct arterial blood pressure measurement:

a) False. A 16-G cannula is far too big to be inserted into an artery. 20-G or 22-G cannulae are usually used allowing adequate blood flow to pass by the cannula distally.

b) True. The position of the dicrotic notch (which represents the closure of the aortic valve) is on the downstroke curve. A high dicrotic notch can be seen in vasoconstricted patients with high peripheral vascular resistance. A low dicrotic notch can be seen in vasodilated patients (e.g. patients with epidurals or sepsis).

c) True. The addition of the shape of the dicrotic notch to an already simple waveform makes a maximum frequency of 40 Hz adequate for such a monitoring system. Because of the complicated waveform of the ECG, the monitoring system requires a much wider range of frequencies (maximum of 100 Hz).

d) False. Increased damping leads to a decrease in systolic pressure and an increase in diastolic pressure. Decreased damping causes the opposite. The mean pressure remains the same.

e) True. This is due to the difference in the compressibility of the two media, air and saline. Air is more compressible in contrast to the saline column.

3. Balloon-tipped flow-guided pulmonary artery catheter:

a) True. The most distal lumen is in the pulmonary artery. There are one or two proximal lumens in the right atrium: one lumen carries the insulated wires leading to the thermistor proximal to the tip of the catheter and another lumen is used to inflate the balloon at the tip of the catheter.

b) False. The cardiac output is measured by thermodilution. A ‘cold’ injectate (e.g. saline) is injected via the proximal lumen. The changes in blood temperature are measured by the thermistor in the pulmonary artery. A temperature–time curve is displayed from which the cardiac output can be calculated.

c) False. Leaving the balloon wedged and inflated is dangerous and should not be done. This is due to the risk of ischaemia to the distal parts of the lungs supplied by the pulmonary artery or its branches.

d) True. Using fibreoptics, the mixed venous oxygen saturation can be measured on some designs. This allows the calculation of oxygen extraction by the tissues.

e) False. A thermistor is used to measure the temperature of the blood. Thermistors are made to very small sizes.

4. If the mean arterial blood pressure is 100 mmHg, pulmonary capillary wedge pressure is 10 mmHg, mean pulmonary artery pressure is 15 mmHg, cardiac output is 5 L/min and CVP is 5 mmHg, which of the following statements are correct?

5. Concerning central venous pressure and cannulation:

6. In an invasive pressure measurement system, which of the following is/are correct:

7. Concerning the oesophageal Doppler:

8. d)

Share this: